![](https://qtxasset.com/quartz/qcloud5/media/image/Asia%20Skyline.jpg?VersionId=D1z8mhSGFGZGeIyVQRyF2XVT.Or1FpKP)
Fierce Pharma Asia—BMS, Eisai's ADC divorce; Takeda's US layoffs; House Speaker's BIOSECURE pledge
After a break for the Fourth of July holiday in the U.S., we're back with two weeks' worth of biopharma news from Asia. During that time, Bristol Myers Squibb returned Eisai's FRα-targeted antibody-drug conjugate. In addition, Takeda …